BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Total Current Assets : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is BioForce Nanosciences Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. BioForce Nanosciences Holdings's total current assets for the quarter that ended in Dec. 2023 was $0.00 Mil.

BioForce Nanosciences Holdings Total Current Assets Historical Data

The historical data trend for BioForce Nanosciences Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioForce Nanosciences Holdings Total Current Assets Chart

BioForce Nanosciences Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

0.06

0.04

0.01

BioForce Nanosciences Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Current Assets	Get a 7-Day Free Trial															-	-	-	-	-

BioForce Nanosciences Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

BioForce Nanosciences Holdings's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.001	+	0	+	0	+	0
	=	0.00

BioForce Nanosciences Holdings's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.001	+	0	+	0	+	0
	=	0.00

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

BioForce Nanosciences Holdings (OTCPK:BFNH) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

BioForce Nanosciences Holdings's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.001	-	1.82	+	0.75 * 0	+	0.5 * 0
=	-1.82

BioForce Nanosciences Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of BioForce Nanosciences Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioForce Nanosciences Holdings Inc (OTCPK:BFNH) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2020 General Booth Boulevard, Suite 230, Virginia Beach, VA, USA, 23454

Website

http://www.bioforceeclipse.com

BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing.

Executives

Richard Kaiser Kaiser	director, 10 percent owner, officer: Secretary/Acting CFO	3419 VIRGINIA BEACH BLVD, UNIT 252, VIRGINIA BEACH VA 23452
Merle Ferguson	director, 10 percent owner, officer: CEO/President/Treasurer	2020 GENERAL BOOTH BLVD., SUITE 230, VIRGINIA BEACH VA 23454
Susan Donohue	10 percent owner	19001 S. RICHFIELD AVE, #102, GREEN VALLEY AZ 85614
Michael D Dunham	director	12000 W PARK PL, EFFECTIVE MANAGEMENT SYSTEMS INC, MILWAUKEE WI 53224
Gregory D Brown	officer: Chief Financial Officer	BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010-8098
Kerry M Frey	officer: Chief Operating Officer	BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE - SUITE 101, AMES IA 50010
Eric Henderson	director, 10 percent owner	BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Lawrence Marshall Gold	director	830 MENLO AVENUE, SUITE 100, MENLO PARK CA 94025
Jean-jacques Sunier	director	BIOFORCE NANOSCIENCES HOLDINGS, INC., 1615 GOLDEN ASPEN DRIVE, SUITE 101, AMES IA 50010
Societe Generale Asset Management Alternative Investments	10 percent owner	170, PLACE HENRI REGNAULT, LADEFENSE, PARIS I0 92043
Ed Cowle	10 percent owner	6 EAST 45TH ST., SUITE 1000, NEW YORK NY 10017
H Deworth Williams	10 percent owner	2681 EAST PARLEYS WAY, SUITE #204, SALT LAKE CITY UT 84109
Carter Robert P Iii	10 percent owner	25 RADCLIFFE DRIVE, VOORHEES NJ 08043
Harvey N Kaye	10 percent owner	190 NW SPANISH RIVER BLVD., SUITE 101, BOCA RATON FL 33431

BioForce Nanosciences Holdings (BioForce Nanosciences Holdings) Headlines

No Headlines